SZUK.F Stock Overview
Primarily engages in the distribution of pharmaceuticals in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Suzuken Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥30.30 |
| 52 Week High | JP¥30.30 |
| 52 Week Low | JP¥28.89 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 4.88% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -14.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| SZUK.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 2.3% |
| 1Y | n/a | 6.9% | 35.1% |
Return vs Industry: Insufficient data to determine how SZUK.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SZUK.F performed against the US Market.
Price Volatility
| SZUK.F volatility | |
|---|---|
| SZUK.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SZUK.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SZUK.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 13,086 | Shigeru Asano | www.suzuken.co.jp |
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies.
Suzuken Co., Ltd. Fundamentals Summary
| SZUK.F fundamental statistics | |
|---|---|
| Market cap | US$2.71b |
| Earnings (TTM) | US$213.08m |
| Revenue (TTM) | US$16.66b |
12.7x
P/E Ratio0.2x
P/S RatioIs SZUK.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SZUK.F income statement (TTM) | |
|---|---|
| Revenue | JP¥2.40t |
| Cost of Revenue | JP¥2.21t |
| Gross Profit | JP¥187.93b |
| Other Expenses | JP¥157.29b |
| Earnings | JP¥30.64b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 12, 2024
| Earnings per share (EPS) | 394.59 |
| Gross Margin | 7.85% |
| Net Profit Margin | 1.28% |
| Debt/Equity Ratio | 0% |
How did SZUK.F perform over the long term?
See historical performance and comparison